← All organizations

ImmuneMed, Inc.

For profitWebsite ↗

Also known as: ImmuneMed, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 31, 2024

Timeline

2000s

Jun 1, 2000
ImmuneMed, Inc.— Founded

Drugs by trial phase (1 distinct, 6 trials)

Phase 2 (1 own, 0 via acquisition)

hzvsf-v13

Indications

Studied for

Pneumonia

Recent trials (6)

NCT06306339Lead sponsorPhase 2Mar 31, 2024
NCT04679350Lead sponsorPhase 2Mar 18, 2021
NCT04679415Lead sponsorPhase 2Dec 31, 2020
NCT04676971Lead sponsorPhase 2Dec 11, 2020
NCT04817202Lead sponsorPhase 1Sep 16, 2020
NCT03653208Lead sponsorPhase 1Oct 31, 2018

Details

Founded: Chuncheon, KR Jun 1, 2000
Last known activity: Mar 31, 2024